跳至主要内容
临床试验/NL-OMON55216
NL-OMON55216尚未招募不适用

Prospective Randomized Controlled Trial To Evaluate The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy (PREDICT-Study) - PREDICT

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 284 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
284

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Male, aged >= 18 years
  • - Prostate cancer patients with a Briganti calculated risk of LN metastases
  • between 5-20% without evidence of metastases on PSMA PET/CT requiring an ePLND
  • in the standard treatment
  • - Scheduled for a (robot-assisted) laparoscopic radical prostatectomy
  • - Written informed consent

排除标准

  • - American Society of Anaesthesiology (ASA) classification > 3
  • - Patients with a contraindication for a lymphadenectomy
  • - Neoadjuvant hormone deprivation therapy
  • - Absence or withdrawal of an informed consent
  • - Evidence of metastases on PSMA PET/CT

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验